3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Other solid neoplasm
1
Gynecologic
1
Gastrointestinal
1
Conditions
Stomach Neoplasms
30
Peritoneal Neoplasms
24
Ovarian Neoplasms
24
Fallopian Tube Neoplasms
13
Carcinoma, Ovarian Epithelial
12
Colorectal Neoplasms
11
Neoplasm Metastasis
5
Appendiceal Neoplasms
5
Recurrence
3
Pancreatic Neoplasms
3
Neoplasms
3
Uterine Neoplasms
2
Sarcoma
2
Pseudomyxoma Peritonei
2
Mesothelioma
2
Hyperthermic Intraperitoneal Chemotherapy
2
Gastric Adenocarcinoma
2
Desmoplastic Small Round Cell Tumor
2
Colonic Neoplasms
2
Carcinoma
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Stage â…¢ Gastric Cancer
1
Rhabdomyosarcoma
1
Rectal Neoplasms
1
Peritoneal Metastases From Gastric Cancer
1
Peritoneal Metastases From Colorectal Cancer
1
Peritoneal Diseases
1
Pelvic Neoplasms
1
Ovarian Epithelial Cancer Recurrent
1
Interventions
Doxorubicin
25
Radiotherapy
15
Ifosfamide
14
Trabectedin
10
pazopanib
6
ribociclib
5
pembrolizumab
5
Specimen Handling
5
Gemcitabine
5
Biopsy
5
palbociclib
4
Magnetic Resonance Spectroscopy
4
Docetaxel
4
Chemotherapy, Adjuvant
4
selinexor
3
liposomal doxorubicin
3
eribulin
3
X-Rays
3
Vincristine
3
Radiation
3
Neoadjuvant Therapy
3
Imatinib Mesylate
3
Filgrastim
3
Etoposide
3
Cyclophosphamide
3
toripalimab
2
temsirolimus
2
romidepsin
2
pegfilgrastim
2
cixutumumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Liposarcoma
×
Hyperthermic Intraperitoneal Chemotherapy
×
Clear all
NCT04213794
2025-02-20
TOASTIT
Mayo Clinic
Phase EARLY_PHASE1
Terminated
2 enrolled